

![]() |
The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy |
|
Authors | ![]() | |
Published in | Acta oncologica. 2017, vol. 56, no. 4, p. 569-574 | |
Abstract | Androgen deprivation (AD) therapy combined to radiotherapy (RT) is a curative therapeutic option for patients with non-metastatic locally advanced or aggressive intermediate prostate cancer (PC), though with a range of nutritional, physical, and psychological side effects. A multidisciplinary care program was created to help frail patients to prevent and manage those side effects. | |
Keywords | Aged — Androgen Antagonists/administration & dosage/adverse effects — Chemoradiotherapy/adverse effects — Counseling — Frail Elderly — Humans — Longitudinal Studies — Male — Middle Aged — Physical Therapy Modalities — Prostatic Neoplasms/psychology/rehabilitation/therapy — Psychotherapy — Quality of Life | |
Identifiers | PMID: 28075176 | |
Full text | ||
Structures | ||
Research groups | Groupe Miralbell Raymond (radio-oncologie) (685) Nutrition clinique (597) | |
Citation (ISO format) | MARESCHAL, Julie et al. The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy. In: Acta Oncologica, 2017, vol. 56, n° 4, p. 569-574. doi: 10.1080/0284186X.2016.1273545 https://archive-ouverte.unige.ch/unige:98935 |